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ARTICLE
A neurovascular high-frequency optical coherence
tomography system enables in situ cerebrovascular
volumetric microscopy
Giovanni J. Ughi 1,2,9, Miklos G. Marosfoi 1,8,9, Robert M. King 1,3, Jildaz Caroff 1,4, Lindsy M. Peterson2,
Benjamin H. Duncan 2, Erin T. Langan1, Amanda Collins 5, Anita Leporati1, Serge Rousselle6,
Demetrius K. Lopes 7, Matthew J. Gounis 1✉ & Ajit S. Puri1
Intravascular imaging has emerged as a valuable tool for the treatment of coronary and
peripheral artery disease; however, no solution is available for safe and reliable use in the
tortuous vascular anatomy of the brain. Endovascular treatment of stroke is delivered under
image guidance with insufficient resolution to adequately assess underlying arterial pathology
and therapeutic devices. High-resolution imaging, enabling surgeons to visualize cerebral
arteries' microstructure and micron-level features of neurovascular devices, would have a
profound impact in the research, diagnosis, and treatment of cerebrovascular diseases. Here,
we present a neurovascular high-frequency optical coherence tomography (HF-OCT) system,
including an imaging console and an endoscopic probe designed to rapidly acquire volumetric
microscopy data at a resolution approaching 10 microns in tortuous cerebrovascular ana-
tomies. Using a combination of in vitro, ex vivo, and in vivo models, the feasibility of HF-OCT
for cerebrovascular imaging was demonstrated.
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Despite tremendous advances in minimally invasive thera-pies, there remain limitations to endovascular treatmentsof brain arteries and aneurysms, largely related to
inadequate visualization techniques. Non-invasive imaging tech-
nologies are unable to provide sufficient resolution to adequately
assess the underlying artery pathology, small perforating arteries,
the device–vessel relationship, and device-related effects such as
platelet aggregation. Intravascular (IV)-imaging solutions are
available for the imaging of coronary and peripheral arteries;
however, they are unsuitable for routine cerebrovascular use.
In the last decade, newer generations of endovascular devices
designed for the cerebrovasculature, such as self-expanding
microstents and flow diverters with struts as small as 25 μm,
have enabled the treatment of wide-neck, complex brain aneur-
ysms1. Given the limited x-ray attenuation of these devices,
radiopaque markers are distributed along the devices to provide
basic fluoroscopy location guidance; however, it is currently not
possible to image the device in its entirety. This is critically
important since an accurate device placement with respect to the
pathology and apposition are necessary for effective treatment
and prevention of disabling complications2,3. Neurovascular
devices require particularly precise placement of the device to
achieve the ultimate goal that is complete exclusion of the
aneurysm from the circulation, and even when angiographic
satisfactory results are achieved acutely, long-term complication
rates remain high4.
Similarly, endovascular thrombectomy has become the standard
of care for eligible patients suffering from ischemic stroke due to a
large vessel occlusion5. Non-invasive imaging techniques such as
magnetic resonance vessel wall imaging have been proposed to
assess vascular damage following thrombectomy6 or to detect
underlying pathology such as intracranial atherosclerosis7; however,
they have an insufficient resolution to directly visualize the vascular
pathology (e.g., intracranial atherosclerotic disease or dissection),
endothelial injury, or thrombosis of perforating arteries.
Volumetric microscopy with the ability to visualize neurovas-
cular devices in their entirety and the vessel wall microstructure
in vivo may have a profound impact in endovascular neurosur-
gery8–10. Endoscopic optical-imaging techniques, with a resolu-
tion approaching the micron scale and feasible incorporation in
small fiber-optics probes, are a promising candidate for a suc-
cessful translation to the clinic11,12. In the last decade, IV optical
coherence tomography (OCT) or optical frequency domain
imaging (OFDI) has become an increasingly popular modality, as
it enables accurate measurements of the coronary lumen mor-
phology, and disease severity13–16. Furthermore, OCT/OFDI has
been extensively used to investigate newer generations of intra-
coronary stent devices17–20. Beyond coronary applications, IV
imaging has the potential to revolutionize the diagnosis and
management of cerebrovascular pathologies21,22; however, until
now, commercial imaging catheters lack the flexibility required to
be advanced in tortuous cerebrovascular anatomy, are not
designed to perform imaging in elevated tortuosity, and are
incompatible with the neurovascular clinical workflow21. As such,
the use of IV imaging in the clinical setting has been restricted to
the posterior circulation of a few selected patients with limited
tortuosity23 and to proximal, non-tortuous segments of internal
carotid arteries24,25. In addition, the field of view (i.e., acquired
image diameter) of the existing devices is insufficient to char-
acterize large and complex carotid arteries with a diameter of
5 mm or more, and intracranial aneurysms. In this study, we
introduce a high-frequency OCT (HF-OCT) imaging system,
including an imaging console and a fiber-optic endoscopic probe
designed for cerebrovascular use and to satisfy these require-
ments, thereby enabling cerebrovascular volumetric in vivo
microscopy.
Results
A neurovascular high-resolution endoscopic imaging system.
We used prototypes of a HF-OCT imaging console and of an
endoscopic probe designed for neurovascular applications to
perform volumetric microscopy in a combination of in vitro,
in vivo, and ex vivo models of cerebrovascular arteries and
therapeutic devices. The term HF-OCT describes a long coher-
ence length frequency domain OCT-imaging system (see
“Methods” section) specifically designed for use in cere-
brovascular anatomy. The probe introduced in this study is
named Vis-M and is a flexible, 0.016-inch (~400 µm) OD wire-
like catheter devised for navigation in tortuous intracranial
anatomy. Contrary to existing IV imaging solutions, the Vis-M
device does not require guidewire supported navigation, and can
be delivered through standard, distal access neurovascular
catheters. The Vis-M optics has the ability to focus and collect
near-infrared light that is back-scattered from the vessel wall,
neurovascular devices, and intraluminal objects. Through a rapid
rotation of the imaging lens within the Vis-M protective sheath
and by retracting the probe through the vessel, the HF-OCT
system performs volumetric imaging of the surrounding artery
and devices at an axial resolution approaching 10 µm (Fig. 1). The
Vis-M is designed to have a comparable profile with state-of-the-
art neurovascular guidewires and features an atraumatic, radio-
paque tip. The catheter construct uses a distal rotational control
solution and avoids the use of a torque cable, resulting in greatly
improved device flexibility and decreased size (see “Methods”
section). This solution enables a significantly reduced crossing
profile, less than half of the diameter and less than a quarter of
the cross-sectional area of commercial IV-imaging solutions13.
These characteristics enable a smooth navigation and reliable
image quality in elevated vascular tortuosity conditions, inac-
cessible with existing IVUS and IV OCT technologies8. The Vis-
M inner optics rotates at a speed of 250 Hz, with each rotation
corresponding to the acquisition of a cross-sectional frame, with a
field of view capable of visualizing arteries with a diameter up to
~7 mm. This frame rate enables the collection of high-resolution,
cross-sectional HF-OCT images from tortuous arterial segments
with a longitudinal spacing of 80 µm, in the example of a 50 mm
pullback acquired in 2 and a half seconds. Shorter or longer
pullback lengths (up to 80 mm) and durations can be selected by
the user to optimize the acquisition parameters for an arterial
segment of a given length.
Fig. 1 Principles of HF-OCT imaging in an intracranial vessel. During a
brief injection of contrast (blue color) through a 5 F distal access catheter,
the Vis-M device is retracted while quickly rotating its internal optics
resulting in a helical scanning pattern. By the means of a tightly spaced
pattern (e.g., 80 µm) and an axial resolution approaching 10 µm,
comprehensive volumetric microscopy of the arterial wall, neurovascular
devices, and intraluminal objects is obtained.
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Vessel clearing in an in vitro model of the circle of Willis. Red
blood cells scatter light and degrade its coherence properties and,
as such, the acquisition of HF-OCT data requires the displace-
ment of arterial blood from the vessel lumen. To test the ability to
infuse sufficient contrast agent for the creation of a suitable
optical window, simulated use experiments were performed at the
main anatomical locations in a patient-specific bench model of
the complete circle of Willis (Supplementary Fig. 1). Omnipaque
350 was identified as the preferred media, having an optimal
viscosity to efficiently displace the blood from the image field of
view. Complete clearance of the internal carotid artery (ICA) was
obtained by flushing at 5 ml/s and was observed after ~2–3 s of
injection. Similarly, clearance of the middle cerebral artery
(MCA) and the vertebral artery (VA) was obtained at a rate of
3 ml/s. The basilar artery (BA) required a 5 ml/s injection to
overcome the inflow from both VAs with the 5 F catheter posi-
tioned at the level of the BA ostium. A rate of 4 ml/s may be able
to provide sufficient clearance when injecting contrast within a
more distal position of the BA23. These results indicate that HF-
OCT acquisitions with a duration of 2 s require injections for a
minimum of 4 s to clear the artery, resulting in a 20 ml injection
of contrast media for the ICA at 5 ml/s and a 12 ml injection for
the MCA at 3 ml/s, similar to clinical protocols for three-
dimensional angiography26.
Imaging in elevated vascular tortuosity in vivo. A flexed fore-
limb swine model (n= 8) provided severe tortuosity conditions in
brachial arteries, with a curvature similar to the human internal
carotid artery siphon27. The tortuosity provided by this in vivo
model cannot reliably be accessed and dependably imaged with
existing IV imaging solutions8. The Vis-M device was tested
bilaterally in brachial arteries (n= 16) acquiring HF-OCT data
sets with an effective imaging length of 65 ± 13 mm. The per-
formance of the Vis-M devices was evaluated by assessing image
artifacts that typically affect state-of-the-art IV technologies in
tortuous anatomy, such as non-uniform rotational distortion
(NURD)28. This artifact occurs when increased friction is exer-











Fig. 2 In vivo imaging in a flexed forelimb model of brachial porcine artery. a The dotted line highlights the estimated path taken by the Vis-M device
through the vessel tortuosity. b HF-OCT microscopy shows the external elastic lamina (arrowheads) and the individual layers of the vessel wall (arrows). A
bright tunica intima is followed by a dark tunica media and a bright adventitia (inset). The asterisks denote the ostia of two side-branches, with diameters
of ~0.2 and 0.7 mm, respectively. c The arrow indicates the eccentric position of the HF-OCT device in the arterial lumen. The image shows a uniform
illumination and absence of NURD artifacts. Imaging in a flexed forelimb swine model was repeated in a total of n= 16 arteries from all animals included in








Fig. 3 HF-OCT volumetric rendering of a stented swine internal maxillary artery. a HF-OCT three-dimensional cutaway rendering (top= distal; bottom
= proximal). Flow-diverter malapposition (arrow) and clots of different sizes (purple color) are visible over the flow-diverter surface. b Cross-sectional HF-
OCT imaging show a jailed branch (asterisk) and several thrombus formations over the flow-diverter surface (arrowheads). c Flow-diverter proximal edge,
with incomplete apposition (3 o’clock) and several clots over the device surface (arrowheads). d Endoscopic view of HF-OCT volumetric rendering. Small,
perforator-like side-branches jailed by a flow-diverting stent are visible. e The side-branch located on the left side of the image (arrow) is free of clots and
the flow-diverting stent is well-apposed to the parent artery. f A second branch located on the right (indicated by the asterisk) shows flow-diverter struts
that are embedded by a clot. Stented arteries data collection was repeated in a total of n= 16 swine internal maxillary arteries, including n= 16 flow-
diverting stents, and n= 15 self-expanding intracranial stents. Scale bars on all HF-OCT images are equal to 1 mm. Three-dimensional rendering color
scheme: red, artery wall; purple, clot; silver, metallic struts.
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it appears on an image as smearing in the circumferential
(rotational) direction, and it causes distortions that may lead to
incorrect interpretation and measurements15. In the elevated
tortuosity of brachial arteries (n= 16), HF-OCT data sets had no
observed NURD artifacts (Fig. 2). Distortion-free imaging with
uniform vessel wall illumination allowed precise visualization of
the individual tissue layers including the internal and external
elastic laminae, detailed lumen anatomy, and the ostia of two
side-branches (Fig. 2b, c).
Imaging of neurovascular stents and flow-diverters in vivo. A
comparison between digital subtraction angiography (DSA),
contrast-enhanced cone beam CT (CBCT), and HF-OCT was
obtained in swine internal maxillary arteries (IMAX, n= 16),
implanted with flow diverting stents (FDS, n= 16), and self-
expandable intracranial stents (ICS, n= 15). Using Fleiss’ kappa
statistic, agreement between expert image readers (n = 3) was
evaluated. Values of 0.90 (HF-OCT), 0.67 (CBCT), and 0.49













Fig. 4 HF-OCT imaging comparison with DSA. a Digital subtraction angiography (DSA) of an internal maxillary artery stented using flow-diverting and
neurovascular stents. The stented segment is indicated by the arrow, with the devices partially overlapping. Corresponding HF-OCT images show
thrombus formations (arrows) not observed on fluoroscopy located over the struts of the flow-diverter at the level of a side branch b, and over the struts of
the flow-diverter and intra-cranial stent in the overlapping segment c. d DSA of a second IMAX artery treated with a flow-diverting stent. The
corresponding HF-OCT cross-sectional images depict device malapposition at different locations not seen on DSA, with maximum extensions of ~0.35mm
e and 0.45mm f. HF-OCT comparison with DSA was repeated for all swine internal maxillary arteries (n= 16), following flow-diverting (n= 16), and self-






Fig. 5 Cross-sectional HF-OCT images compared to corresponding CBCT slices. a A side-branch thrombosis is visible on the HF-OCT image (arrow). b
Flow-diverter malapposition with a maximum severity of ~400 µm is visible on the HF-OCT image between 1 and 8 o’clock. Small thrombus formations
over the flow-diverter struts, with a thickness between ~30 and 220 µm, are indicated by the arrowheads. The presence of thrombus and device
malapposition are often undetected on the corresponding cone beam CT images. c Thrombosis on the ostium of a large side-branch. HF-OCT comparison
with CBCT was repeated for all swine internal maxillary arteries (n= 16), following flow-diverting (n= 16), and self-expanding intracranial stent
implantation (n= 15). Scale bars on HF-OCT images are equal to 1 mm. The star symbol (*) on CT images denotes the location of side-branches.
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formation along the surface of the FDS. Similarly, values of 0.87
(HF-OCT), 0.67 (CBCT), and 0.18 (DSA) were found for the
diagnosis of FDS malapposition. A repeated analysis for the ICS
device showed an agreement of 0.81 (HF-OCT), 0.39 (CBCT),
and 0.71 (DSA) for thrombus accumulation, and values of 0.78
(HF-OCT), 0.45 (CBCT), and 0.41 (DSA) for malapposition. The
relatively good agreement documented on DSA for the presence
of thrombus on the ICS was further analyzed. Assuming
as ground-truth the observations from HF-OCT, although the
reviewers agreed on the DSA studies, more than half of the cases
were false-negatives.
Examples of imaging data following FDS implantation are
shown in Fig. 3. HF-OCT captured the presence of thrombus
accumulation and incomplete device apposition in a comprehen-
sive fashion (Fig. 3a). Similarly, a side-branch occlusion and FDS
edge malapposition covered by multiple thrombi are accurately
depicted (Fig. 3b, c). Three-dimensional endoscopic data
rendering illustrates two perforator-like branches jailed by a
FDS (Fig. 3d), including the presence or absence of clots over
their ostia (Fig. 3e, f). HF-OCT and corresponding DSA and
CBCT data are shown in Figs. 4 and 5. Clots as small as 30 µm
(Figs. 4b, c and 5b), malapposition of the device (Fig. 4e, f), and
side-branch thrombosis (Fig. 5a, c) are captured by HF-OCT
microscopy images, but are unseen on the corresponding DSA
and CBCT images. Further examples of the ability of HF-OCT to















Fig. 6 HF-OCT volumetric microscopy of an intracranial stent partially overlapping with the distal end of a flow diverting stent. a Three-dimensional
rendering showing significant thrombus accumulation. b HF-OCT microscopy depicts the vessel wall microstructure including the individual vessel layers
comprising a bright tunica intima, a low-scattering tunica media, and the tunica adventitia (arrows). The internal elastic lamina (IEL) and the external elastic
lamina (EEL) are indicated by the green arrows. c A thrombus dislodged from the surface of the device floating inside a large branch is visible and denoted
by the asterisk. d Thrombus formations ranging between 100 and 200 µm in thickness are indicated by the asterisks and distributed over the FDS surface.
e A semi-occlusive clot formation in correspondence of a significant malapposition (>500 µm) is visible over the proximal end of the FDS. HF-OCT imaging
was repeated in a total of n= 15 swine internal maxillary arteries with an intracranial stent partially overlapping with a flow-diverting stent. Scale bars are








Fig. 7 Intracranial plaques from an ex vivo segment of the MCA artery. a HF-OCT imaging of a fibrotic plaque and corresponding trichrome b and
Movat’s staining c. Fibrotic tissue is characterized by HF-OCT as a region of homogenous signal, resulting from elevated backscattering and low optical
attenuation coefficients. d HF-OCT imaging of a necrotic core plaque and corresponding H&E e and Movat’s staining f. A necrotic core plaque is
characterized on HF-OCT images as an area with poorly delineated borders followed by an elevated optical attenuation coefficient within an atherosclerotic
plaque. The asterisk indicates a vessel wall dissection. From n= 10 cadaveric specimens of intracranial arteries, a total of n= 3 representative
atherosclerotic plaques were identified, processed for histopathology analysis, and compared to HF-OCT imaging. Scale bars are equal to 1.0 mm.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17702-7 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:3851 | https://doi.org/10.1038/s41467-020-17702-7 | www.nature.com/naturecommunications 5
shown in Fig. 6, including the interaction between two over-
lapping devices. Furthermore, a dislodged thrombus in the ostium
of a side branch and a partial vessel occlusion as a result of
significant thrombosis over a malapposed FDS proximal edge are
illustrated in Fig. 6b, e.
Imaging in large arteries. To investigate the ability of HF-OCT
to image large carotid arteries, additional stenting of swine
common carotids was performed in a subgroup of the animals
(n= 5). The diameter of the stented segments was found to be on
average 5.5 ± 0.3 mm, with a maximum diameter of 5.9 mm. In all
cases, the extended field of view of the Vis-M device provided
sufficient illumination to accurately assess the stent-vessel inter-
action on a strut level (Supplementary Fig. 2).
Imaging of intracranial atherosclerosis. Segments of diseased
intracranial arteries (n= 10) were obtained at autopsy from
patients older than 70 years of age with a history of vascular
disease. An expert image reader identified a subset of the arterial
segments containing representative examples of the three main
plaque types. Representative cases of fibrotic, fibrocalcific, and
necrotic core (NC) atherosclerotic disease were found (n= 3).
Tissue was processed by the means of histopathology techniques
and stained using Sudan’s black, hematoxylin and eosin (H&E),
van Gieson’s, Movat Pentachrome, and Trichrome reagents. A
vascular pathologist blinded to HF-OCT-imaging results analyzed
the stained slices and characterized the plaques and tissue type.
Agreement was found in all cases (n= 3).
A fibrotic plaque located in the M1 segment of the MCA of a
cadaver of 97 years of age is shown in Fig. 7a. Fibrotic tissue was
identified on HF-OCT images as a thicker region of the artery
wall exhibiting elevated optical backscattering and homogeneous
intensity in the near-infrared spectrum15. Histopathology assess-
ment categorized this plaque to be mostly composed of fibrotic
tissue (Fig. 7b, c). A second plaque containing a NC is illustrated
in Fig. 7d. NCs were identified on HF-OCT images as signal-poor
areas with poorly delineated boundaries within an atherosclerotic
plaque covered by a fibrous cap: necrotic tissue presents a strong
optical attenuation in the near-infrared range, resulting in a rapid
image intensity signal drop-off with distance into tissue,
shadowing the vessel wall region located behind15. In agreement
with the HF-OCT findings, histopathology classified this plaque
as fibrotic containing a NC and underlying media degeneration
(Fig. 7e, f). Lastly, a fibrocalcific plaque was identified in the distal
segment of an intradural VA from a cadaver of 86 years of age.
HF-OCT displays fibrocalcific plaques to contain evidence of
fibrotic and calcific tissue, characterized by a signal-poor and
heterogeneous region with sharply delineated borders15. A
fibrocalcific plaque, with a circumferential distribution of 87°
and a maximum thickness of ~900 µm is shown in Fig. 8b.
Calcific tissue presents low backscattering and attenuation
coefficients in the near-infrared range and, as a result, HF-OCT
can accurately visualize both its thickness and circumferential
distribution. Histopathology assessment categorized this plaque
as mostly calcific in agreement with HF-OCT image assessment,
with evidence of underlying media degeneration and positive
remodeling.
Discussion
High-resolution IV imaging has the potential to provide sufficient
spatial resolution to visualize details of neurovascular arteries and
therapeutic devices at a strut level that are unseen by state-of-the-
art clinical imaging modalities. Previous research has shown the
potential of IV imaging techniques for neurovascular
applications8,21; however, due to the mechanical characteristics of
the existing catheter-based imaging devices, their translation to
tortuous cerebrovasculature was unfeasible. The data presented in
this study illustrates how the proposed neurovascular HF-OCT
system, including a miniaturized, flexible, endovascular-imaging
probe enables comprehensive volumetric optical microscopy of
intracranial arteries. Using a patient-specific in vitro model of the
complete circle of Willis, we have presented translatable contrast
injection protocols permitting IV optical imaging at different
neurovascular anatomical locations. The optimized protocols
established for HF-OCT do not differ from routine practice in
neurointerventional surgery for the acquisition of rotational
angiography data, and their acquisitions could occur simulta-
neously. In an animal model, we collected evidence of the suit-
ability of the Vis-M device for use in elevated vascular tortuosity,
comparable to the tortuosity conditions encountered in the
human ICA where existing IV-imaging devices cannot reliably be
used8. Volumetric HF-OCT microscopy resulted in a much
higher inter-operator agreement for the quantification of intra-
luminal clots and for the assessment of the interaction between
neurovascular devices and the arterial wall, compared to state-of-
the-art imaging modalities such as DSA and CBCT. Furthermore,
we illustrated the ability of HF-OCT to visualize the micro-
structure of the vessel wall, including characterization of intra-
cranial atherosclerosis. Taken together, the results of this study
pave the way for the clinical translation of high-resolution
endovascular imaging for cerebrovascular use.
A growing body of pre-clinical evidence supports the premise
that high-resolution cerebrovascular imaging, with the ability to
assess vessel wall disease and neurovascular devices, will have a
significant impact on the endovascular treatment of cere-
brovascular disease8–10,21,29,30. Recently, it has been shown that
in a leporine in vivo model the complete apposition of flow-
diverting stents is critically important to achieve early and com-
plete aneurysm occlusion, but histological evidence of poor
apposition was not accurately captured on gold-standard DSA
imaging2. In a second study, communicating malapposition
between the aneurysm neck and flow-diverting devices, captured
by IV OCT but unseen on x-ray modalities, was shown to be a




Fig. 8 Intracranial fibrocalcific plaques in a segment of an intradural
vertebral artery. a Two fibrocalcific plaques are visible in the image. A
smaller plaque with a calcium thickness between 100 and 300 µm is
located at 11 o’clock. A larger plaque with a calcium maximum thickness of
900 µm is located in the bottom-left quadrant of the image. bMagnification
showing fine details of the plaque microstructure, including inner and outer
boundaries. On HF-OCT, calcific tissue is characterized by a sharply
demarcated area with a weaker and heterogeneous signal, resulting from a
low optical backscattering and low absorption coefficients. Characterization
of HF-OCT versus histopathology for imaging of fibrocalcific plaques
was obtained from one intracranial artery specimen. Scale bars are equal
to 1 mm.
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intrasaccular device reconstruction of aneurysm necks observed
by HF-OCT and undetected on CBCT were shown to correlate
with failed aneurysm occlusion29. Magnetic resonance is the
method of choice for intracranial vessel wall imaging in the
context of ischemic stroke and intracranial hemorrhage, however,
its accuracy is significantly affected by its limited spatial resolu-
tion and voxel size. A recent investigation showed that the higher
resolution of IV imaging was able to reveal endothelial injuries,
residual thrombus, and ongoing thrombosis of BA perforators at
the lesion site following endovascular thrombectomy, in cases
where non-invasive angiographic techniques, including CT
angiography and magnetic resonance, showed a complete reca-
nalization, free of residual thrombus23.
The introduced neurovascular HF-OCT system enables volu-
metric microscopy of the arterial wall at a resolution approaching
10 µm. In this study, we have shown that high-resolution IV
imaging can accurately identify intraluminal thrombus and
neurovascular devices at a strut level in vivo. These results, in
combination with the evidence provided for imaging in tortuous
anatomy, suggest that HF-OCT can be used clinically for peri-
procedural assessment of neurovascular devices so that corrective
measures, such as local administration of GP IIb/IIIa inhibitors,
angioplasty, or additional stenting, can be deployed. In cases
where angiographic findings are ambiguous, its superior resolu-
tion allows the visualization of vessel dissections and stent–vessel
interactions which non-invasive imaging techniques are unable to
capture. An accurate characterization of intracranial athero-
sclerotic plaque types may inform treatment decisions, as well as
enable improved stent sizing, placement, and interaction with
perforating arteries and residual stenosis for an improved treat-
ment of intracranial arteries22,32,33. Furthermore, cerebrovascular
volumetric microscopy by HF-OCT can enable more informed,
image guided, personalized antithrombotic management follow-
ing endovascular treatements23. Its enhanced resolution has the
ability to study the vessel and aneurysm healing response to an
implanted device at an unparalleled level, assessing the tissue
thickness over the device surface and vascular remodeling, with
precision and accuracy of microscopy techniques in vivo29,34. As
such, the use of cerebrovascular HF-OCT offers great potential
for monitoring device healing in clinical practice, assessing
endothelial overgrowth and intimal hyperplasia35, offering
insights for optimal antiplatelet therapy following endovascular
treatments36. Similarly, in pre-clinical settings, HF-OCT will
provide key insights supporting the development and advance-
ment of future generations of neurovascular devices.
With this study, we introduced a neurovascular HF-OCT-
imaging system designed to perform cerebrovascular volumetric
microscopy. In a combination of in vitro, ex vivo, and in vivo
models, we demonstrated the feasibility of a miniaturized HF-
OCT endoscopic probe to image tortuous intracranial vascular
anatomy, and the ability to visualize fine details of the arterial wall
microstructure and its interaction with endovascular devices in
high-resolution. The results presented here indicate the potential
of HF-OCT technology for use in intracranial arteries and its
superiority with respect to state-of-the-art noninvasive imaging
modalities to provide additional guidance for neuroendovascular
therapeutic procedures.
The ability to inject contrast media and achieve a clear optical
window for imaging of neurovascular arteries was investigated in a
bench model of the circle of Willis. Substantial efforts were made to
reproduce patient circulation, including pulsatile blood flow, phy-
siological flow rates, vessel caliber, and capillary resistance. How-
ever, the use of in vitro models may be unable to capture the large
spectrum of anatomical variations and disease conditions encoun-
tered in patient cerebrovasculature. In this study, a higher viscosity
agent was more effective in successfully displacing blood from the
vessel lumen and obtain a clear field of view. To elaborate further,
given that a relatively low amount of residual blood can deteriorate
HF-OCT image quality (Supplementary Fig. 3B), a higher viscosity
media can help to obtain a complete, circumferential, clear field of
view more easily, for an optimal image quality acquisition. In
clinical practice, other factors such as intracranial artery disease,
aging, and consequent reduction of blood flow may permit the use
of lower viscosity agents, such as saline, reduced viscosity contrast,
or a mixture of both. In these conditions, injection at lower rates
may also be possible and provide sufficient clearance for HF-OCT
acquisitions. Furthermore, the use of low molecular weight dextran
has been successfully demonstrated for coronary imaging37, safety
was investigated for intracranial use38, and future studies may
possibly explore its use for HF-OCT imaging. Similarly, the use of
saline or partial dilution with contrast have been demonstrated for
IV imaging of coronaries and carotid arteries39. As a matter of fact,
both saline and dextran are optically transparent media that can be
effectively used for HF-OCT imaging. However, as they both pre-
sent a reduced viscosity40, injections at higher flow rates will be
often required to obtain a fully cleared lumen in vessels with flow
rates of 4ml/s or above. Nevertheless, in more distal vessels or in
vessels with impaired flow conditions, the use of saline or dextran
may permit good quality imaging as illustrated by previous cor-
onary and peripheral arteries studies37,41. Similarly, balloon tech-
niques for proximal occlusion during injection can drastically
reduce the blood flow in the target artery and reduce the injection
rates of saline, dextran, or contrast. Even though meaningful HF-
OCT acquisitions can be acquired through injections limited to 20
ml of contrast or less, saline or dextran may be adopted to avoid or
further reduce contrast administration in patients with renal
insufficiency and other underlying conditions. In routine clinical
workflow, rotational angiography is used for diagnosis and treat-
ment planning of cerebrovascular disease. Given the speed with
which the HF-OCT device acquires images (e.g., 50mm vessel
length in 2.5 s), the optimized contrast injection protocol is con-
sistent with that used during rotational angiography allowing for
simultaneous acquisitions (rotational angiography and HF-OCT)
thereby reducing contrast load.
Methods
Neurovascular HF-OCT-imaging system. In this study, HF-OCT data were
collected using prototypes of a neurovascular HF-OCT-imaging system, including
an imaging console and an endoscopic-imaging probe, named Vis-M® (Gentuity,
Sudbury, MA). HF-OCT describes a long coherence length frequency domain
OCT-imaging system specifically designed for use in cerebrovascular anatomy. The
term ‘high frequency’ is used to differentiate the technology introduced in this
study from existing commercially available frequency domain OCT (FD-OCT)/
OFDI IV imaging solutions13. As HF-OCT was designed to address neurovascular
imaging requirements, it acquires data at a significantly increased A-line rate and
with an extended field of view, generating and collecting signals at higher fre-
quencies. The HF-OCT prototype presented in this study utilizes a central light
wavelength of 1300 nm, it has an A-scan line rate of 200 kHz, an axial resolution
approaching 10 µm in tissue, and an effective imaging radius of ~7 mm in contrast
(diameter of 14 mm), assuming a refractive index n= 1.45 for this media40. In
comparison, commercially available solutions for intracoronary OCT imaging
acquire data at 90 kHz, with an imaging radius of 4.8 mm in contrast. The imaging
range of the HF-OCT system allows to visualize neurovascular arteries and
aneurysms that are up to ~7 mm in diameter, taking into consideration the worst
possible scenario where the imaging probe is located in the most eccentric position
with respect to the vessel centerline. The Vis-M is a 0.016-inch wire-like catheter
device (~400 µm maximum diameter), comprising a distal atraumatic, radiopaque
tip. A miniaturized graded index (GRIN) lens is attached to a bend insensitive
optical fiber and it is used to focus and collect the backscattered light from the
arterial wall, neurovascular devices, and other intraluminal objects. The imaging
lens spins within a protective, optically transparent device sheath at a speed of 250
Hz, collecting an equal number of cross-sectional images per second. The device is
retracted either manually by the operator or at a pullback speed pre-selected by the
user (Fig. 1), and can image arterial segments with a length up to 80 mm in a single
acquisition. In case of a 50 mm long pullback sampled in two and a half seconds
(i.e., pullback speed of 20 mm/s), the resulting HF-OCT spacing is equal to 80 µm.
The primary innovation that enabled device miniaturization and ideal flexibility for
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cerebrovascular navigation is the elimination of traditional torque cable solutions
adopted by existing IV-imaging technologies, such as IVUS42 and IV OCT43. In the
Vis-M construct, a distal rotational control solution comprising a viscous gel is
adopted, such that the optical fiber itself can be used to reliably transmit the
rotational torque between the system and the distal-imaging lens. From the results
presented in this study, it is possible to appreciate how this solution not only allows
for a flexible and reduced size endoscopic probe, but also enables a satisfactory
image quality collection in conditions showing a severe vascular tortuosity, com-
parable to the one encountered in human anatomy (Fig. 2). In these situations,
traditional torque cable solutions fails, presenting stiffness and safety characteristics
not optimized for cerebrovascular use8.
Patient-specific vascular model of the circle of Willis. A patient-specific vas-
cular model including the entire circle of Willis was used to investigate optimal
blood clearing protocols at different anatomical locations including the internal
carotid, the middle cerebral, the intradural vertebral, and the basilar arteries
(Supplementary Fig. 1). Flow sensors and a pressure sensor were used to constantly
measure the ICA, MCA, and BA flow rates and monitor the MCA pressure.
Compressor clamps were used on the model outlets to adjust peripheral vasculature
resistance, and ensure the reproduction of clinically relevant pressure and flow
values44. Swine blood was maintained at 37 °C and circulated using a pulsatile
pump. The resistance of the outlets was adjusted to achieve physiologically
representative flow rates through each branch of the model. Blood pressure and
flow rate was constantly monitored and adjusted to maintain physiological values
of ~250 ml/min in the ICA, 140 ml/min in the MCA, and 160 ml/min in the BA.
Importantly, the model includes communicating arteries that have the potential to
mix with injected contrast and obscure the acquisition of HF-OCT images.
A pulsatile pump was used to circulate swine blood, and the optimal contrast
injection protocols were identified at the location of the ICA, MCA, BA, and VA
arteries. For each of these locations, the Vis-M device was delivered to the target
anatomy and contrast media infused via a power injector through a 5 F intracranial
distal access catheter (Navien, Medtronic Neurovascular, Irvine, CA). Different
concentrations of Omnipaque (GE Healthcare, Marlborough, MA) were tested,
including 240, 300, and 350 mgI/mL with a viscosity of 3.4, 6.3, and 10.4 cp at
37 °C, respectively. Injections were performed using an automated pump (Medrad
Mark 7 Arterion Injection System, Bayer HealthCare, Whippany, NJ) flushing
through the 0.058-inch inner lumen of the intracranial distal access catheter at a
pressure limit of 300 psi. Starting from 1ml/s and using increments of 0.5 ml/s, the
flow rate was increased until complete clearance was obtained and the optimal
flushing protocol for each anatomical location determined. Clearance as a function
of the contrast delivery rate was analyzed using a HF-OCT-imaging metric by
classifying the results in three categories: blood obscuring the field of view, partial
clearance, and complete clearance (Supplementary Fig. 3).
Animal model and preparation. A Yorkshire swine model ranging between 40
and 70 kg (n= 8) was used in this study in accordance with our University’s
Institutional Animal Care and Use Committee (IACUC). All procedures were
performed under general anesthesia. The animals were pre-anesthetized by a
subcuticular injection of glycopyrrolate (0.01 mg/kg). Anesthesia was induced by
an intramuscular injection of tiletamine (Telazol, 4.4 mg/kg), ketamine (2.2 mg/kg),
and xylazine (2.2 mg/kg) and was maintained through mechanical ventilation of
1–3% isoflurane. During the procedure, the following vital parameters were
monitored continuously and recorded: heart and respiratory rate, invasive blood
pressure, oxygen saturation, end-tidal CO2, and temperature.
A model of elevated vascular tortuosity was obtained by the means of a flexed
forelimb model. This technique is able to provide severe tortuosity in brachial
arteries, resulting in radii of curvature similar to the ones encountered in the
human ICA27. After the surgical exposure of the right femoral artery, a 10 F
introducer sheath was inserted for endovascular access and a 5 F Navien™
(Medtronic) was navigated through the proximal segment of the brachial artery
allowing the deployment of the Vis-M device to the target anatomy.
The 5 F intracranial distal access catheter was subsequently navigated into the
internal maxillary artery (IMAX). FDS (n= 16) were deployed bilaterally into the
IMAX. A Pipeline FDS (Medtronic) was used in half of the arteries (n= 8), and a
Surpass FDS (Stryker neurovascular) was implanted in the other half (n= 8) by the
means of conventional endovascular surgery techniques. Following FDS
implantation, an ICS was deployed in each IMAX resulting in a partially
overlapping segment. Wingspan stents (Stryker Neurovascular) were implanted in
a total of five arteries, Neuroform stents (Stryker Neurovascular) in six arteries, and
Solitaire AB stents (Medtronic) in four arteries, for a total of 15 devices. In one
single case, no ICS was deployed due to a thrombotic occlusion of the artery at the
distal end of the FDS. In addition, a Precise Pro Carotid stent system (Cordis) was
implanted in a subset of the animals in the common carotid artery (n= 5).
Acquisition of imaging data. HF-OCT imaging was performed bilaterally in swine
brachial arteries of all animals (n= 16). Contrast media (Omnipaque) was injected
by the means of a 5 F distal access catheter to displace blood from the arterial
lumen. IV HF-OCT images were acquired in all IMAX arteries, following the
deployment of FDS and ICS devices, obtaining a total of 31 imaging runs. Sixteen
(n= 16) of these imaging data set were acquired following the FDS implantation.
The additional datasets (n= 15) were obtained following the ICS implantation
partially overlapping with the FDS. Similarly, DSA, non-subtracted cineangio-
graphy, and full-scale, small FOV cone-beam CT images (Philips Healthcare) were
acquired for each vessel using standard imaging techniques, obtaining 31 imaging
runs for each modality.
Analysis of neurovascular devices. Expert image readers (n= 3) analyzed the
presence of thrombus accumulation along the device and malapposition using a
binary outcome metric across the different modalities. Reviewers analyzed a total of
480 images that included angiographic runs, HF-OCT and CBCT cross-sectional
images in a blinded fashion. Fleiss’ kappa statistic was used to assess the agreement
between the different reviewers. A binary scoring system was used to classify all
images for the presence or absence of clots and device malapposition. Prior to
image quantification, co-registration of the imaging data from the different mod-
alities was obtained using the distal and proximal edges of the FD and ICS as
reference markers. Regions of interests (ROI) of 5 mm in length were defined at the
proximal and distal edges of all devices. For each ROI, the locations containing the
largest clot and the most severe malapposition were matched between DSA, HF-
OCT, and the reconstructed CBCT cross-sectional images.
Ex vivo segments of intracranial artery. To compare HF-OCT imaging of intra-
cranial atherosclerotic plaques with histopathology, we obtained arterial segments
from cadavers older than 70 years of age with a history of smoking and coronary or
peripheral artery disease. All specimens were provided by the University of Massa-
chusetts Medical School Division of Translational Anatomy. Per NIH and the Uni-
versity of Massachusetts Medical School IRB guidelines, specimens from deceased
individuals are not human subjects research. Consent to use remains for medical
research was provided by donors prior to being deceased. The intracranial vasculature
of human cadavers was explored (n= 3), and multiple arteries appearing to contain
atherosclerotic disease were collected (n= 10). Segments of the distal internal carotid
artery (n= 2), MCA (n= 4), basilar (n= 2), and intradural vertebral (n= 2) arteries
were harvested. Specimens were traditionally fixated with a 10% formalin solution and
subsequently submerged in saline for HF-OCT acquisitions. Multiple data sets cap-
turing volumetric data from the entire length of each artery were obtained. An expert
image reader identified regions of interest containing atherosclerotic disease for
fibrotic, fibrocalcific, and NC plaques (n= 3). Similarly to state-of-art near-infrared IV
OCT technology15, fibrotic plaque tissue was identified by a homogeneous signal with
relatively high backscattering; calcific tissue as low attenuation and signal-poor het-
erogeneous tissue with sharply demarcated borders; necrotic tissue as high-attenuating,
resulting in poorly delineated borders, fast signal drop-off, and little or no signal
backscattering15,45. A visible light indicator emitted by the Vis-M catheter was used to
mark each region of interest on the different specimens. The corresponding tissue
samples were subsequently embedded in paraffin, sectioned in 5 µm slices, and pro-
cessed for Sudan’s black, H&E, van Gieson’s, Movat pentachrome, and trichrome
staining.
Statistical analysis. Unless otherwise specified, data are presented as mean ±
standard deviation. Fleiss’ kappa statistics was used to assess and quantify the
agreement between the three different image raters classifying DSA, CBCT, and
HF-OCT images. Mean and standard deviation statistics were calculated using
Microsoft Excel. Fleiss’s kappa for inter-rater agreement was calculated using R
(Vienna, Austria).
Three-dimensional HF-OCT renderings. Cross-sectional images were manually
processed and segmented using software ImageJ (NIH). Intraluminal clots, struts of
neurovascular devices, and the contour of the vessel wall were identified, manually
traced, and labeled. HF-OCT data were rendered in color using the following
scheme: red, artery wall; purple, intraluminal clots; silver, metallic struts. The
segmented data sets were imported into a volume-rendering DICOM visualization
software (OsiriX MD v10.0.2, Pixmeo SARL, Bernex, Switzerland), after a frame-to-
frame registration to correct for motion artifacts generated by the mechanical
scanning of the catheter (Image J)46. Perspective volume rendering techniques
using cut surfaces and fly-through methods with manually optimized opacity tables
were used for visualization16.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The imaging data that support the findings of this study are available from the
corresponding author upon reasonable request.
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